Journal of Cerebral Blood Flow & Metabolism · 1985 · 41 citations · 31 references
MedicineNeurobiologyPharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsCerebral Blood FlowCerebrovascular PhysiologyCerebral Blood Flow AlterationsCerebral Blood Flow RegulationCerebral HemodynamicsCerebral VasodilationLeukotriene PharmacologyPeripheral VasodilationPial VasculatureTopical Application
To determine the possible role that leukotrienes (LTs) may play in the regulation of cerebral blood flow, the responses of cerebral arterioles to LTs and 12-hydroxyeicosatetraenoic acid (12-HETE) were studied in vivo in rabbits equipped with a cranial window for direct observation of the microcirculation. Topical application of LTC4, LTD4, or 12-HETE (1.6 X 10(-9)-3.1 X 10(-6) M) neither constricted nor dilated the pial arteries. LTB4 produced only a 5% vasoconstriction at 3.0 X 10(-6) M. However, bradykinin induced dose-dependent arteriolar vasodilation and histamine and 5-hydroxytryptamine induced dose-dependent arteriolar vasoconstriction. Although some LTs have potent vasoconstrictor activity in peripheral tissues and 5-lipoxygenase products have been hypothesized to be mediators of vasospasm after subarachnoid hemorrhage, LTB4, LTC4, LTD4, and 12-HETE apparently are unable to induce significant constriction of the cerebral arterioles in the anesthetized rabbit.
31
Leukotrienes are potent constrictors of human bronchi
Sven‐Erik Dahlén, Per Hedqvist, Sven Hammarström et al. · Nature · 1980 · 972 citations
Medicine, Pharmacology, Physiology +11